Furthermore, an adequate independent external validation (i.e., mucin mRNA measurements at baseline, during infection, and after infection) in other COVID-19 and concurrent non–COVID-19 age-matched cohorts is recommended to elucidate the prognostic/predictive potential of this peripheral mucin mRNA signature for COVID-19. The gene discussed is MUC5AC; the disease is infection.